Loomis Sayles & Co. L P bought a new stake in Stevanato Group S.p.A. (NYSE:STVN – Free Report) during the second quarter, Holdings Channel.com reports. The fund bought 561,971 shares of the company’s stock, valued at approximately $13,729,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Invesco Ltd. bought a new position in shares of Stevanato Group in the 1st quarter worth $19,072,000. Champlain Investment Partners LLC purchased a new position in Stevanato Group in the first quarter worth $15,741,000. MetLife Investment Management LLC bought a new position in Stevanato Group in the first quarter valued at $12,944,000. Artisan Partners Limited Partnership raised its position in Stevanato Group by 20.0% during the second quarter. Artisan Partners Limited Partnership now owns 2,733,782 shares of the company’s stock valued at $66,786,000 after purchasing an additional 455,323 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. lifted its stake in Stevanato Group by 13.3% during the first quarter. T. Rowe Price Investment Management Inc. now owns 3,744,714 shares of the company’s stock worth $76,468,000 after purchasing an additional 439,722 shares during the last quarter.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the company. Morgan Stanley increased their price objective on Stevanato Group from $24.00 to $26.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Stevanato Group in a research report on Monday, November 24th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.
Stevanato Group Trading Up 2.0%
NYSE STVN opened at €23.36 on Monday. The firm has a market cap of $7.07 billion, a PE ratio of 40.98, a price-to-earnings-growth ratio of 2.29 and a beta of 0.57. Stevanato Group S.p.A. has a 1-year low of €17.81 and a 1-year high of €28.00. The stock has a 50-day moving average of €24.53 and a 200-day moving average of €24.30. The company has a current ratio of 1.89, a quick ratio of 1.30 and a debt-to-equity ratio of 0.26.
Stevanato Group Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Read More
- Five stocks we like better than Stevanato Group
- How to Choose Top Rated Stocks
- Worried About Inflation? These 3 ETFs Offer Real Protection
- The Significance of Brokerage Rankings in Stock Selection
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- The How And Why of Investing in Oil Stocks
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
